Pure Global

"Parkson" Baimetrino Fress drug releases coronary stent system - Taiwan Registration 4fcd4655a6d1d2edc2ff60a23857ae18

Access comprehensive regulatory information for "Parkson" Baimetrino Fress drug releases coronary stent system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 4fcd4655a6d1d2edc2ff60a23857ae18 and manufactured by BIOSENSORS EUROPE SA;; BIOSENSORS INTERVENTIONAL TECHNOLOGIES PTE LTD.. The authorized representative in Taiwan is IDS MEDICAL SYSTEMS (HONG KONG) COMPANY LIMITED, TAIWAN BRANCH (HONG KONG).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
4fcd4655a6d1d2edc2ff60a23857ae18
Registration Details
Taiwan FDA Registration: 4fcd4655a6d1d2edc2ff60a23857ae18
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Parkson" Baimetrino Fress drug releases coronary stent system
TW: โ€œๆŸ็››โ€ๆ‹œ็พŽ็ฟ ๅฐผๅฅงๅผ—้›ท็ตฒ่—ฅ็‰ฉ้‡‹ๆ”พๅ† ็‹€ๅ‹•่„ˆๆ”ฏๆžถ็ณป็ตฑ
Risk Class 3

Registration Details

4fcd4655a6d1d2edc2ff60a23857ae18

DHA05602655807

Product Details

For details, it is Chinese approved copy of the imitation order

E Cardiovascular Medicine Science

E.0001 Cardiovascular stents

import

Dates and Status

Sep 12, 2014

Sep 12, 2024